Menu
VOL. 12, NO. 6 • JUNE 2019 Dear Colleagues: Welcome to the
Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has
J Clin Aesthet Dermatol. 2019;12(6):17–24 by James Q. Del Rosso, DO, FAOCD,
J Clin Aesthet Dermatol. 2019;12(6):27–28 by Brooke Vasicek, MD; William Adams, PhD;
J Clin Aesthet Dermatol. 2019;12(6):30–41 by James Q. Del Rosso, DO; Theodore
